Literature DB >> 18622084

Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.

U H Lerner1, E Persson.   

Abstract

Immunohistochemical phenotypic characterization of skeletal nerve fibers has demonstrated the expression of a restricted number of neuropeptides, including calcitonin gene-related peptide (CGRP), substance P (SP) and vasoactive intestinal peptide (VIP). According to the neuro-osteological hypothesis, such neuropeptides can be released and exert paracrine biological effects on bone cells present close to the nerve endings expressing these signaling molecules. The existence of such interplay is most convincingly shown by the hypothalamic control of bone formation, in the case of leptin stimulation of hypothalamic nuclei mediated by the sympathetic nervous system and inhibitory beta-adrenergic receptors on osteoblasts. In addition to these receptors, osteoblasts and osteoclasts express functional receptors for CGRP, SP and VIP, which can regulate both bone formation and bone resorption. The evidence for these observations is summarized in the present paper.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622084

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  34 in total

1.  Crosstalk between the brain and bone.

Authors:  Laura Masi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

2.  Expression of neuropeptides and bone remodeling-related factors during periodontal tissue regeneration in denervated rats.

Authors:  Xijiao Yu; Linlin Lv; Jing Zhang; Ting Zhang; Changjie Xiao; Shu Li
Journal:  J Mol Histol       Date:  2015-02-07       Impact factor: 2.611

3.  Hydrolysis of substance P in the presence of the osteosarcoma cell line SaOS-2: release of free amino acids.

Authors:  Antonella Cavazza; Mario Marini; L Giorgio Roda; Umberto Tarantino; Angela Valenti
Journal:  Neurochem Res       Date:  2011-08-21       Impact factor: 3.996

4.  Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.

Authors:  Sayako Nonaka; Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Teruko Takano-Yamamoto
Journal:  Cell Mol Neurobiol       Date:  2013-06-26       Impact factor: 5.046

5.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

6.  Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.

Authors:  V H Avilés-Rosas; E Rivera-Mancilla; B A Marichal-Cancino; G Manrique-Maldonado; A H Altamirano-Espinoza; A Maassen Van Den Brink; C M Villalón
Journal:  Br J Pharmacol       Date:  2017-05-02       Impact factor: 8.739

7.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 8.  Heterotopic ossification in orthopaedic trauma.

Authors:  Aaron Nauth; Erica Giles; Benjamin K Potter; Leon J Nesti; Frederick P Oʼbrien; Michael J Bosse; Jeffrey O Anglen; Samir Mehta; Jaimo Ahn; Theodore Miclau; Emil H Schemitsch
Journal:  J Orthop Trauma       Date:  2012-12       Impact factor: 2.512

9.  Alterations of sympathetic nerve fibers in avascular necrosis of femoral head.

Authors:  Deqiang Li; Peilai Liu; Yuankai Zhang; Ming Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  A genome-wide association study suggests that a locus within the ataxin 2 binding protein 1 gene is associated with hand osteoarthritis: the Treat-OA consortium.

Authors:  G Zhai; J B J van Meurs; G Livshits; I Meulenbelt; A M Valdes; N Soranzo; D Hart; F Zhang; B S Kato; J B Richards; F M K Williams; M Inouye; M Kloppenburg; P Deloukas; E Slagboom; A Uitterlinden; T D Spector
Journal:  J Med Genet       Date:  2009-06-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.